Panduan Hemofilia: Pengertian, Pengobatan, dan Penggunaan Obat Yang Aman Dan Berisiko
Keywords:
Hemofilia, Obat yang Aman, Pengobatan HemofiliaSynopsis
Hemofilia adalah salah satu penyakit genetik yang termasuk penyakit langka; dengan prevalensi kasus 1 banding 6.000-10.000 kelahiran bayi laki-laki di seluruh dunia. Meskipun begitu, angka kasus yang tercatat saat ini cukup besar, lebih dari 200.000 kasus hemofilia di seluruh dunia, dengan estimasi kasus di Indonesia adalah mencapai 27.000 kasus. Namun yang sudah berhasil tegak diagnosa hanya kurang lebih tiga ribu kasus, akibat kurangnya akses informasi dan akses kesehatan terkait hemofilia di Indonesia. Himpunan Masyarakat Hemofilia Indonesia (HMHI) memperkirakan bahwa jumlah pasien hemofilia yang terdaftar hanya sekitar 10% dari total estimasi pasien. Hemofilia kerap kali disalahpahami oleh masyarakat. Kurangnya informasi yang akurat dan terbatasnya sumber bacaan yang mudah dipahami sering kali menjadi kendala bagi para penyintas hemofilia, keluarga, serta tenaga kesehatan dalam memberikan perawatan yang optimal. Buku Panduan Hemofilia: Pengertian, Pengobatan, dan Penggunaan Obat yang Aman dan Berisiko ini saya tulis dengan harapan dapat menjadi referensi yang komprehensif dan mudah diakses oleh masyarakat luas, khususnya komunitas hemofilia. Saya ingin berbagi pemahaman mengenai hemofilia, mulai dari aspek medis hingga pengobatan yang tersedia, termasuk perhatian khusus terhadap penggunaan obat-obatan yang aman maupun yang berisiko bagi penyintas hemofilia. Dorongan terbesar dalam penulisan buku ini adalah pengalaman pribadi saya yang kehilangan buah hati akibat perdarahan otak yang disebabkan oleh hemofilia. Kesedihan yang mendalam ini saya ubah menjadi motivasi untuk memberikan manfaat bagi mereka yang masih berjuang menghadapi kondisi ini. Saya berharap buku ini dapat membantu keluarga, pasien, serta tenaga medis dalam memahami hemofilia lebih baik dan memberikan perawatan yang lebih aman dan tepat.Semoga buku ini bermanfaat dan dapat menjadi salah satu langkah kecil dalam meningkatkan kesadaran serta kualitas hidup para penyintas hemofilia di Indonesia. Buku Panduan Hemofilia: Pengertian, Pengobatan, dan Penggunaan Obat yang Aman dan Berisiko hadir sebagai sumber informasi yang komprehensif mengenai hemofilia. Buku ini diawali dengan pemaparan dasar tentang hemofilia, termasuk sejarah, mekanisme pembekuan darah, penyebab penyakit, serta manifestasi klinisnya. Selain itu, disajikan pula data mengenai prevalensi hemofilia yang dapat membantu dalam memahami sejauh mana penyakit ini berdampak di berbagai populasi. Selanjutnya, buku ini mengulas berbagai terapi yang tersedia untuk penderita hemofilia, mulai dari metode konvensional hingga pendekatan modern yang lebih inovatif. Pembahasan ini bertujuan untuk memberikan wawasan kepada pasien dan tenaga kesehatan mengenai opsi pengobatan terbaik yang dapat meningkatkan kualitas hidup penderita hemofilia. Salah satu aspek krusial yang dibahas dalam buku ini adalah penggunaan obat-obatan yang dapat meningkatkan risiko perdarahan pada penderita hemofilia. Beberapa kelompok obat, seperti antiinflamasi non-steroid (OAINS), kortikosteroid, antikoagulan, antidepresan, antibiotik, hingga suplemen herbal, dikaji secara mendalam terkait efek sampingnya terhadap sistem pembekuan darah. Dengan memahami risiko yang ditimbulkan oleh obat-obatan tertentu, pembaca diharapkan dapat lebih berhati-hati dalam memilih terapi yang aman. Ditulis berdasarkan pengalaman pribadi penulis serta didukung oleh literatur ilmiah yang valid, buku ini ditujukan bagi penderita hemofilia, keluarga, tenaga kesehatan, serta siapa pun yang ingin memahami lebih dalam tentang kondisi ini. Harapannya, buku ini dapat menjadi panduan yang bermanfaat dalam meningkatkan kesadaran, memperbaiki strategi pengobatan, dan membantu penderita hemofilia menjalani kehidupan yang lebih baik dan lebih sehat.
Downloads
Download data is not yet available.
References
Abebe, W. 2002a. “Herbal Medication: Potential for Adverse Interactions with Analgesic Drugs.” Journal of Clinical Pharmacy and Therapeutics 27(6):391–401. doi: 10.1046/j.1365-2710.2002.00444.x.
Abebe, W. 2002b. “Herbal Medication: Potential for Adverse Interactions with Analgesic Drugs.” Journal of Clinical Pharmacy and Therapeutics 27(6):391–401. doi: 10.1046/j.1365-2710.2002.00444.x.
Ay, Cihan, Laurent Frenzel, Karen Pinachyan, and Sandra Le Quellec. 2024. “Gene Therapy for Haemophilia A and B, from Basic Principles to Clinical Implementation: An Illustrated Review.” Haemophilia 30(1):5–15. doi: 10.1111/hae.14907.
Aymonnier, Karen, Charlotte Kawecki, Laurence Venisse, Yacine Boulaftali, Olivier D. Christophe, Peter J. Lenting, Véronique Arocas, Emmanuelle de Raucourt, Cécile V. Denis, and Marie-Christine Bouton. 2019. “Targeting Protease Nexin-1, a Natural Anticoagulant Serpin, to Control Bleeding and Improve Hemostasis in Hemophilia.” Blood 134(19):1632–44. doi: 10.1182/blood.2019000281.
Badulescu, Oana-Viola, Dragos Viorel Scripcariu, Minerva Codruta Badescu, Manuela Ciocoiu, Maria Cristina Vladeanu, Carmen Elena Plesoianu, Andrei Bojan, Dan Iliescu-Halitchi, Razvan Tudor, Bogdan Huzum, and Iris Bararu Bojan. 2024. “Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk.” International Journal of Molecular Sciences 25(14):7845. doi: 10.3390/ijms25147845.
Baillargeon, Jacques, Holly M. Holmes, Yu-Li Lin, Mukaila A. Raji, Gulshan Sharma, and Yong-Fang Kuo. 2012. “Concurrent Use of Warfarin and Antibiotics and the Risk of Bleeding in Older Adults.” The American Journal of Medicine 125(2):183–89. doi: 10.1016/j.amjmed.2011.08.014.
Balkaransingh, Pauline, and Guy Young. 2018. “Novel Therapies and Current Clinical Progress in Hemophilia A.” Therapeutic Advances in Hematology 9(2):49–61. doi: 10.1177/2040620717746312.
Bates, Daniel, B. Carsten Schultheis, Michael C. Hanes, Suneil M. Jolly, Krishnan V Chakravarthy, Timothy R. Deer, Robert M. Levy, and Corey W. Hunter. 2019. “A Comprehensive Algorithm for Management of Neuropathic Pain.” Pain Medicine 20(Supplement_1):S2–12.
van den Berg, H. M., P. H. G. De Groot, and K. Fischer. 2007. “Phenotypic Heterogeneity in Severe Hemophilia.” Journal of Thrombosis and Haemostasis : JTH 5 Suppl 1:151–56. doi: 10.1111/j.1538-7836.2007.02503.x.
Berntorp, Erik, and Amy D. Shapiro. 2012. “Modern Haemophilia Care.” Lancet (London, England) 379(9824):1447–56. doi: 10.1016/S0140-6736(11)61139-2.
Bertamino, Marta, Francesca Riccardi, Laura Banov, Johanna Svahn, and Angelo Claudio Molinari. 2017. “Hemophilia Care in the Pediatric Age.” Journal of Clinical Medicine 6(5). doi: 10.3390/jcm6050054.
Bordia, Arun. 1978. “Effect of Garlic on Human Platelet Aggregation in Vitro Arun Bordia.” Atherosclerosis 30(4):355–60. doi: 10.1016/0021-9150(78)90129-6.
Chaudhry, Raheel, Syed Muhammad Usama, and Hani M. Babiker. 2023. “Physiology, Coagulation Pathways.”
Choi, Jun-Hui, Kumar Sapkota, Se-Eun Park, Seung Kim, and Sung-Jun Kim. 2013. “Thrombolytic, Anticoagulant and Antiplatelet Activities of Codiase, a Bi-Functional Fibrinolytic Enzyme from Codium Fragile.” Biochimie 95(6):1266–77. doi: 10.1016/j.biochi.2013.01.023.
Chung, K. F., M. Mccusker, C. P. Page, G. Dent, PH. Guinot, and P. J. Barnes. 1987. “EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN.” The Lancet 329(8527):248–51. doi: 10.1016/S0140-6736(87)90066-3.
Coppens, Michiel, Steven W. Pipe, Wolfgang Miesbach, Jan Astermark, Michael Recht, Paul van der Valk, Bruce Ewenstein, Karen Pinachyan, Nicholas Galante, Sandra Le Quellec, Paul E. Monahan, Frank W. G. Leebeek, and HOPE-B Investigators. 2024. “Etranacogene Dezaparvovec Gene Therapy for Haemophilia B (HOPE-B): 24-Month Post-Hoc Efficacy and Safety Data from a Single-Arm, Multicentre, Phase 3 Trial.” The Lancet. Haematology 11(4):e265–75. doi: 10.1016/S2352-3026(24)00006-1.
Coppola, Antonio, Jerzy Windyga, Antonella Tufano, Cindy Yeung, and Matteo Nicola Dario Di Minno. 2015. “Treatment for Preventing Bleeding in People with Haemophilia or Other Congenital Bleeding Disorders Undergoing Surgery.” Cochrane Database of Systematic Reviews 2015(2). doi: 10.1002/14651858.CD009961.pub2.
Doshi, Bhavya S., and Valder R. Arruda. 2018. “Gene Therapy for Hemophilia: What Does the Future Hold?” Therapeutic Advances in Hematology 9(9):273–93. doi: 10.1177/2040620718791933.
Fleming, Thomas. 1998. PDR for Herbal Medicines.
Frazier, Heather, Sean Dougherty, Kia Salafian, and Hillary S. Maitland. 2023. “Impact of Anticoagulation in Acquired Hemophilia a.” Blood 142(Supplement 1):5541–5541. doi: 10.1182/blood-2023-174131.
Ge, Beikang, Zhen Zhang, and Zhong Zuo. 2014. “Updates on the Clinical Evidenced Herb‐Warfarin Interactions.” Evidence-Based Complementary and Alternative Medicine 2014(1). doi: 10.1155/2014/957362.
Guillet, Benoît, Guillaume Cayla, Aurélien Lebreton, Nathalie Trillot, Bénédicte Wibaut, Céline Falaise, Sabine Castet, Philippe Gautier, Ségolène Claeyssens, and Jean-François Schved. 2021. “Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.” Thrombosis and Haemostasis 121(03):287–96. doi: 10.1055/s-0040-1718410.
Haemophilia Foundation Australia. 2024. “Haemophilia Inheritance.” Retrieved March 15, 2025 (https://www.haemophilia.org.au/bleeding-disorders/haemophilia/haemophilia-inheritance/).
Hao, Xingpei, Hang Xiao, Jihyeung Ju, Mao-Jung Lee, Joshua D. Lambert, and Chung S. Yang. 2017. “Green Tea Polyphenols Inhibit Colorectal Tumorigenesis in Azoxymethane-Treated F344 Rats.” Nutrition and Cancer 69(4):623–31. doi: 10.1080/01635581.2017.1295088.
Heck, Amy M., Beth A. DeWitt, and Anita L. Lukes. 2000. “Potential Interactions between Alternative Therapies and Warfarin.” American Journal of Health-System Pharmacy 57(13):1221–27. doi: 10.1093/ajhp/57.13.1221.
Hegde, Ajay, Rajesh Nair, and Sunil Upadhyaya. 2016. “Spontaneous Intracerebral Hemorrhage in Hemophiliacs-A Treatment Dilemma.” International Journal of Surgery Case Reports 29:17–19. doi: 10.1016/j.ijscr.2016.10.046.
Holt, Anders, Jarl E. Strange, Peter Vibe Rasmussen, Paul Blanche, Nina Nouhravesh, Mads Hashiba Jensen, Anne-Marie Schjerning, Morten Schou, Christian Torp-Pedersen, Gunnar H. Gislason, Morten Lock Hansen, Patricia McGettigan, and Morten Lamberts. 2022. “Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran.” The American Journal of Medicine 135(5):595-602.e5. doi: 10.1016/j.amjmed.2021.11.008.
James, Paula D., Sanj Raut, Georges E. Rivard, Man-Chiu Poon, Margaret Warner, Susan McKenna, Jayne Leggo, and David Lillicrap. 2005. “Aminoglycoside Suppression of Nonsense Mutations in Severe Hemophilia.” Blood 106(9):3043–48. doi: 10.1182/blood-2005-03-1307.
Kim, Hyemee, Hae-Jeung Lee, Dae Joong Kim, Tae Myoung Kim, Hyun-Seuk Moon, and Haymie Choi. 2013. “Panax Ginseng Exerts Antiproliferative Effects on Rat Hepatocarcinogenesis.” Nutrition Research 33(9):753–60. doi: 10.1016/j.nutres.2013.07.005.
Kruse-Jarres, Rebecca, Christine L. Kempton, Francesco Baudo, Peter W. Collins, Paul Knoebl, Cindy A. Leissinger, Andreas Tiede, and Craig M. Kessler. 2017. “Acquired Hemophilia A: Updated Review of Evidence and Treatment Guidance.” American Journal of Hematology 92(7):695–705. doi: 10.1002/ajh.24777.
Kubatka, Peter, Martin Kello, Karol Kajo, Peter Kruzliak, Desanka Výbohová, Ján Mojžiš, Marián Adamkov, Silvia Fialová, Lucia Veizerová, Anthony Zulli, Martin Péč, Dagmar Statelová, Daniel Grančai, and Dietrich Büsselberg. 2017. “Oregano Demonstrates Distinct Tumour-Suppressive Effects in the Breast Carcinoma Model.” European Journal of Nutrition 56(3):1303–16. doi: 10.1007/s00394-016-1181-5.
Kuo, Sheng-Chu, Che-Ming Teng, Jang-Chang Lee, Feng-Nien Ko, Sheng-Chih Chen, and Tian-Shung Wu. 1990. “Antiplatelet Components in Panex Ginseng.” Planta Medica 56(02):164–67. doi: 10.1055/s-2006-960916.
De La Cruz, J. P., M. Martín-Romero, J. A. Carmona, M. A. Villalobos, and F. Sánchez de la Cuesta. 1997. “EFFECT OF EVENING PRIMROSE OIL ON PLATELET AGGREGATION IN RABBITS FED AN ATHEROGENIC DIET.” Thrombosis Research 87(1):141–49. doi: 10.1016/S0049-3848(97)00113-8.
Laporte, Silvy, Céline Chapelle, Pascal Caillet, Marie-Noëlle Beyens, Florelle Bellet, Xavier Delavenne, Patrick Mismetti, and Laurent Bertoletti. 2017. “Bleeding Risk under Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: A Meta-Analysis of Observational Studies.” Pharmacological Research 118:19–32. doi: 10.1016/j.phrs.2016.08.017.
Lee, Anna, Po Tong Chui, Cindy ST Aun, Tony Gin, and Angel SC Lau. 2004. “Possible Interaction Between Sevoflurane and Aloe Vera.” Annals of Pharmacotherapy 38(10):1651–54. doi: 10.1345/aph.1E098.
Loomans, Janneke I., Marieke J. H. A. Kruip, Manuel Carcao, Shannon Jackson, Alice S. van Velzen, Marjolein Peters, Elena Santagostino, Helen Platokouki, Erik Beckers, Jan Voorberg, Johanna G. van der Bom, Karin Fijnvandraat, and RISE consortium. 2018. “Desmopressin in Moderate Hemophilia A Patients: A Treatment Worth Considering.” Haematologica 103(3):550–57. doi: 10.3324/haematol.2017.180059.
Mahlangu, Johnny, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth C. Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S. Key, Michael Laffan, Amy L. Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D. Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T. Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B. Reddy, Joshua Henshaw, Tara M. Robinson, Wing Yen Wong, Steven W. Pipe, and GENEr8-1 Trial Group. 2023. “Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.” The New England Journal of Medicine 388(8):694–705. doi: 10.1056/NEJMoa2211075.
Marano, Giuseppe, Romano Arcieri, Rosalba Elisabetta Rocchi, Arianna Annunziata, Maria Cutillo, Giampaolo Bucaneve, Roberto Da Cas, and Mariangela Rossi. 2024. “Use of Antidepressant and Antipsychotic Drugs in Subjects with Hemophilia of the Umbria Region in the Period 2011-2022.” Annali Dell’Istituto Superiore Di Sanita 60(3):208–15. doi: 10.4415/ANN_24_03_06.
Mehta, Parth, and Anil Kumar Reddy Reddivar. 2023. “Hemophilia .” Statpearls. Retrieved March 15, 2025 (https://www.ncbi.nlm.nih.gov/books/NBK551607/).
Merskey, Harold Ed. 1986. “Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms.” Pain.
Nagao, Azusa, Yushi Chikasawa, Yukio Hiroi, and Masahiro Ieko. 2024. “Treatment of Thrombotic Cardiovascular Diseases in People with Haemophilia: A Japanese Consensus Study.” Haemophilia 30(4):933–42. doi: 10.1111/hae.15039.
Nakamura, Michiko, Sayaka Miura, Akiko Takagaki, and Fumio Nanjo. 2017. “Hypolipidemic Effects of Crude Green Tea Polysaccharide on Rats, and Structural Features of Tea Polysaccharides Isolated from the Crude Polysaccharide.” International Journal of Food Sciences and Nutrition 68(3):321–30. doi: 10.1080/09637486.2016.1232376.
Nochaiwong, Surapon, Chidchanok Ruengorn, Ratanaporn Awiphan, Chatree Chai-Adisaksopha, Apichat Tantraworasin, Chabaphai Phosuya, Penkarn Kanjanarat, Wilaiwan Chongruksut, Manish M. Sood, and Kednapa Thavorn. 2022. “Use of Serotonin Reuptake Inhibitor Antidepressants and the Risk of Bleeding Complications in Patients on Anticoagulant or Antiplatelet Agents: A Systematic Review and Meta-Analysis.” Annals of Medicine 54(1):80–97. doi: 10.1080/07853890.2021.2017474.
Nutescu, Edith A. 2013. “Oral Anticoagulant Therapies: Balancing the Risks.” American Journal of Health-System Pharmacy 70(10_Supplement_1):S3–11. doi: 10.2146/ajhp130040.
Ozelo, Margareth C., Johnny Mahlangu, K. John Pasi, Adam Giermasz, Andrew D. Leavitt, Michael Laffan, Emily Symington, Doris V Quon, Jiaan-Der Wang, Kathelijne Peerlinck, Steven W. Pipe, Bella Madan, Nigel S. Key, Glenn F. Pierce, Brian O’Mahony, Radoslaw Kaczmarek, Joshua Henshaw, Adebayo Lawal, Kala Jayaram, Mei Huang, Xinqun Yang, Wing Y. Wong, Benjamin Kim, and GENEr8-1 Trial Group. 2022. “Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.” The New England Journal of Medicine 386(11):1013–25. doi: 10.1056/NEJMoa2113708.
Pabinger, Ingrid, Dietmar Fries, Herbert Schöchl, Werner Streif, and Wolfgang Toller. 2017. “Tranexamic Acid for Treatment and Prophylaxis of Bleeding and Hyperfibrinolysis.” Wiener Klinische Wochenschrift 129(9–10):303–16. doi: 10.1007/s00508-017-1194-y.
Parisi, Kate, and Abhishek Kumar. 2023. “Emicizumab.” Statpearls Internet. Retrieved March 17, 2025 (https://www.ncbi.nlm.nih.gov/books/NBK559180/).
PENNING-VAN BEEST, F. J. A., J. KOERSELMAN, and R. M. C. HERINGS. 2008. “Risk of Major Bleeding during Concomitant Use of Antibiotic Drugs and Coumarin Anticoagulants.” Journal of Thrombosis and Haemostasis 6(2):284–90. doi: 10.1111/j.1538-7836.2008.02844.x.
Peyvandi, Flora, Isabella Garagiola, and Guy Young. 2016. “The Past and Future of Haemophilia: Diagnosis, Treatments, and Its Complications.” Lancet (London, England) 388(10040):187–97. doi: 10.1016/S0140-6736(15)01123-X.
Pipe, Steven W. 2012. “The Hope and Reality of Long-Acting Hemophilia Products.” American Journal of Hematology 87 Suppl 1:S33-9. doi: 10.1002/ajh.23146.
Pipe, Steven W., Frank W. G. Leebeek, Michael Recht, Nigel S. Key, Giancarlo Castaman, Wolfgang Miesbach, Susan Lattimore, Kathelijne Peerlinck, Paul Van der Valk, Michiel Coppens, Peter Kampmann, Karina Meijer, Niamh O’Connell, K. John Pasi, Daniel P. Hart, Rashid Kazmi, Jan Astermark, Cedric R. J. R. Hermans, Robert Klamroth, Richard Lemons, Nathan Visweshwar, Annette von Drygalski, Guy Young, Shelley E. Crary, Miguel Escobar, Esteban Gomez, Rebecca Kruse-Jarres, Doris V Quon, Emily Symington, Michael Wang, Allison P. Wheeler, Robert Gut, Ying P. Liu, Ricardo E. Dolmetsch, David L. Cooper, Yanyan Li, Brahm Goldstein, and Paul E. Monahan. 2023. “Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.” The New England Journal of Medicine 388(8):706–18. doi: 10.1056/NEJMoa2211644.
Raso, S., and C. Hermans. 2018. “Recombinant Factor VIII: Past, Present and Future of Treatment of Hemophilia A.” Drugs of Today (Barcelona, Spain : 1998) 54(4):269–81. doi: 10.1358/dot.2018.54.4.2800622.
Rogaev, Evgeny I., Anastasia P. Grigorenko, Gulnaz Faskhutdinova, Ellen L. W. Kittler, and Yuri K. Moliaka. 2009. “Genotype Analysis Identifies the Cause of the ‘Royal Disease’.” Science (New York, N.Y.) 326(5954):817. doi: 10.1126/science.1180660.
Rosenblatt, Marc, and Joel Mindel. 1997. “Spontaneous Hyphema Associated with Ingestion of Ginkgo Biloba Extract.” New England Journal of Medicine 336(15):1108–1108. doi: 10.1056/NEJM199704103361518.
Salen, Philip, and Hani M. Babiker. 2025. Hemophilia A.
SATTLER, FRED R., MICHAEL R. WEITEKAMP, and JAMES O. BALLARD. 1986. “Potential for Bleeding with the New Beta-Lactam Antibiotics.” Annals of Internal Medicine 105(6):924–31. doi: 10.7326/0003-4819-105-6-924.
Schramm, Wolfgang. 2014. “The History of Haemophilia - a Short Review.” Thrombosis Research 134 Suppl 1:S4-9. doi: 10.1016/j.thromres.2013.10.020.
Schutgens, Roger E. G., Victor Jimenez-Yuste, Miguel Escobar, Anna Falanga, Bruna Gigante, Robert Klamroth, Riitta Lassila, Frank W. G. Leebeek, Michael Makris, Tarek Owaidah, Michelle Sholzberg, Andreas Tiede, David J. Werring, H. Bart van der Worp, Jerzy Windyga, and Giancarlo Castaman. 2023. “Antithrombotic Treatment in Patients With Hemophilia: An EHA-ISTH-EAHAD-ESO Clinical Practice Guidance.” HemaSphere 7(6):e900. doi: 10.1097/HS9.0000000000000900.
Shetty, Shrimati, Sonal Vora, Bipin Kulkarni, Leenam Mota, Manasi Vijapurkar, Leera Quadros, and Kanjaksha Ghosh. 2007. “Contribution of Natural Anticoagulant and Fibrinolytic Factors in Modulating the Clinical Severity of Haemophilia Patients.” British Journal of Haematology 138(4):541–44. doi: 10.1111/j.1365-2141.2007.06693.x.
Srivastava, A., A. K. Brewer, E. P. Mauser-Bunschoten, N. S. Key, S. Kitchen, A. Llinas, C. A. Ludlam, J. N. Mahlangu, K. Mulder, M. C. Poon, A. Street, and Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. 2013. “Guidelines for the Management of Hemophilia.” Haemophilia : The Official Journal of the World Federation of Hemophilia 19(1):e1-47. doi: 10.1111/j.1365-2516.2012.02909.x.
Stonebraker, J. S., P. H. B. Bolton-Maggs, J. Michael Soucie, I. Walker, and M. Brooker. 2010. “A Study of Variations in the Reported Haemophilia A Prevalence around the World.” Haemophilia : The Official Journal of the World Federation of Hemophilia 16(1):20–32. doi: 10.1111/j.1365-2516.2009.02127.x.
Stromer, Waltraud, Ingrid Pabinger, Cihan Ay, Richard Crevenna, Josef Donnerer, Clemens Feistritzer, Sophie Hemberger, Rudolf Likar, Florian Sevelda, Katharina Thom, Barbara Wagner, and Werner Streif. 2021. “Pain Management in Hemophilia: Expert Recommendations.” Wiener Klinische Wochenschrift 133(19–20):1042–56. doi: 10.1007/s00508-020-01798-4.
Vaes, Leon PJ, and Peter A. Chyka. 2000. “Interactions of Warfarin with Garlic, Ginger, Ginkgo, or Ginseng: Nature of the Evidence.” Annals of Pharmacotherapy 34(12):1478–82. doi: 10.1345/aph.10031.
Wilson, Ryan, Chae Ko, and Rahul Kashyap. 2024. “COVID-19 in the Setting of HIV and Severe Hemophilia A: A Case Report.” HCA Healthcare Journal of Medicine 5(2). doi: 10.36518/2689-0216.1615.
Yang, Chao, Lihua Li, Ligang Yang, Hui Lǚ, Shaokang Wang, and Guiju Sun. 2018. “Anti-Obesity and Hypolipidemic Effects of Garlic Oil and Onion Oil in Rats Fed a High-Fat Diet.” Nutrition & Metabolism 15(1):43. doi: 10.1186/s12986-018-0275-x.
Zimmerman, Bree, and Leonard A. Valentino. 2013. “Hemophilia: In Review.” Pediatrics in Review 34(7):289–94; quiz 295. doi: 10.1542/pir.34-7-289
Downloads
Published
March 25, 2025
Series
Categories
Copyright (c) 2025 Nadiya Nurul Afifah, Indra Wijaya (Author)
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Details about this monograph
ISBN-13 (15)
978-623-10-8715-7
How to Cite
Afifah, N. N., & Wijaya, I. (2025). Panduan Hemofilia: Pengertian, Pengobatan, dan Penggunaan Obat Yang Aman Dan Berisiko. Media Kunkun Nusantara. https://omp.mediakunkun.com/index.php/book/catalog/book/18
